ODEFSEY®▼

(emtricitabine / rilpivirine / tenofovir alafenamide)

ODEFSEY® is a once-daily single-tablet regimen1 containing:

  • emtricitabine (FTC) and tenofovir alafenamide fumarate (TAF); two nucleoside reverse transcriptase inhibitors (NRTIs), and
  • Rilpivirine (RPV); a non-nucleoside reverse transcriptase inhibitor (NNRTI).